Hasil Pencarian - Jason Luke

  • Menampilkan 1 - 13 hasil dari 13
Perbaiki Hasil
  1. 1
    Monitoring regulation of DNA repair activities of cultured cells in-gel using the comet assay

    Monitoring regulation of DNA repair activities of cultured cells in-gel using the comet assay oleh Jason Luke Parsons, Catherine Marie Nickson

    Diterbitkan 2014-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    489 The impact of education on novel concepts in adjuvant melanoma: a closer look at high risk stage II disease

    489 The impact of education on novel concepts in adjuvant melanoma: a closer look at high risk stage II disease oleh Charlotte Warren, Jason Luke, Emily Van Laar

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    392 A phase 1a/b study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally dvanced or metastatic solid tumors and urothelial carcinoma

    392 A phase 1a/b study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally dvanced or metastatic solid tumors and urothelial carcinom... oleh Jason Luke, Meredith McKean, Nehal Lakhani, Katherine Kacena, Alan Tan, Babar Bashir, David Aggen, Marissa Timothy, Sergio Santillana

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    500 SYNB1891, a bacterium engineered to produce a STING agonist, demonstrates target engagement in humans following intratumoral injection

    500 SYNB1891, a bacterium engineered to produce a STING agonist, demonstrates target engagement in humans following intratumoral injection oleh Filip Janku, Jason Luke, Sarina Piha-Paul, Karl Lewis, James Strauss, Mary Varterasian, Anna Sokolovska, Richard Riese, Michael Armstrong, Claire Verschraegen, Aoife Brennan

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors

    512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors oleh Igor Puzanov, Jason Luke, Anthony Olszanski, Dan Lu, Stella Martomo, Jeegar Patel, Christos Fountzilas, Lee Rosen, Adrian Hackett, Olivier Schueller, David Eiznhamer, Alessandro Mora, Miranda Ross

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors

    782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors oleh Jason Luke, Ahmad A Tarhini, Anthony J Olszanski, Chen Zhu, Giovanni Abbadessa, Christos Fountzilas, Lee Rosen, Adyb Baakili, Timothy Wagenaar, Helene Guillemin-Paveau, Meijing Wu, Raymond Perez

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    701 Activating CD73 on B cells as a target for immunotherapy of COVID-19 and viral associated cancers: clinical activity in human papilloma virus positive (HPV) head and neck squamous cell cancers (HNSCC)

    701 Activating CD73 on B cells as a target for immunotherapy of COVID-19 and viral associated cancers: clinical activity in human papilloma virus positive (HPV) head and neck squam... oleh Igor Puzanov, Richard Miller, Jason Luke, Jeffrey Sosman, Thomas Marron, Brett Hughes, Abhishek Tripathi, Mehrdad Mobasher, Craig Hill, Shenshen Hu, Suresh Mahabhashyam, Kristen Marrone, Jaime Merchan, James Janc, Jenny Rudnick

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    313 A phase 1 evaluation of tebotelimab, a bispecific PD-1 x LAG-3 DART® molecule, in combination with margetuximab in patients with advanced HER2+ neoplasms

    313 A phase 1 evaluation of tebotelimab, a bispecific PD-1 x LAG-3 DART® molecule, in combination with margetuximab in patients with advanced HER2+ neoplasms oleh Xiaoyu Zhang, Sanjeev Kaul, Paul Moore, Jason Luke, Bartosz Chmielowski, Hedy Kindler, Francine Chen, George Blumenschein, Erika Hamilton, Shakeela Bahadur, Cesar Santa-Maria, Janine Koucheki, Jichao Sun, John Muth, Patrick Kaminker, Bradley Sumrow

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma

    304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in a... oleh Kim Margolin, Antoni Ribas, Riyue Bao, Adil Daud, Mohammed Milhem, Elizabeth Buchbinder, Geoffrey Gibney, Jason Luke, Takami Sato, David Mauro, Yousef Zakharia, Theresa Medina, John Kirkwood, Jiaxin Niu, Katie Campbell, George Weiner, Inderjit Mehmi, Heather Kelley, James Wooldridge

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp

    538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp oleh Joseph Sacco, Richard Carvajal, Omid Hamid, Marcus Butler, Jason Luke, Takami Sato, Paul Nathan, Jessica Hassel, Douglas Johnson, Leonel Hernandez-Aya, Alexander Shoushtari, Josep Piulats, Enrique Espinosa, Serge Leyvraz, Alexandra Ikeguchi, Matthew Rioth, Chris Holland, Michelle McCully, Shaad Abdullah

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melanoma

    950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melano... oleh Hong Liu, Kim Margolin, Antoni Ribas, Adil Daud, Mohammed Milhem, Elizabeth Buchbinder, Geoffrey Gibney, Jason Luke, Diwakar Davar, Takami Sato, Bartosz Chmielowski, Luping Zhao, Yousef Zakharia, Theresa Medina, John Kirkwood, Jiaxin Niu, Anthony Olszanski, Montaser Shaheen, George Weiner, Arthur Krieg, Inderjit Mehmi, Heather Kelley, James Wooldridge, Dmitri Bobilev

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA203 trial

    959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA2... oleh Harpreet Singh, Jason Luke, Mamta Kalra, Martin Wermke, Dejka Araujo, Ali Mohamed, Winfried Alsdorf, Apostolia-Maria Tsimberidou, Andrea Mayer-Mokler, Arun Satelli, Carsten Reinhardt, Dominik Maurer, George Jr Blumenschein, Kerstin Guenther, Manik Chatterjee, Norbert Hilf, Regina Mendrzyk, Steffen Walter, Stephen Eck, Tobias AW Holderried, Toni Weinschenk, Van Morris, Cedrik M Britten

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

    Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) oleh Sneha Berry, Nicolas Giraldo, Peter Nguyen, Benjamin Green, Haiying Xu, Aleksandra Ogurtsova, Abha Soni, Farah Succaria, Daphne Wang, Charles Roberts, Julie Stein, Elizabeth Engle, Drew Pardoll, Robert Anders, Tricia Cottrell, Janis M. Taube, Ben Tran, Mark Voskoboynik, James Kuo, Yung-Lue Bang, Hyun-Cheo Chung, Myung-Ju Ahn, Sang-We Kim, Ayesh Perera, Daniel Freeman, Ikbel Achour, Raffaella Faggioni, Feng Xiao, Charles Ferte, Charlotte Lemech, Funda Meric-Bernstam, Theresa Werner, Stephen Hodi, Wells Messersmith, Nancy Lewis, Craig Talluto, Mirek Dostalek, Aiyang Tao, Sarah McWhirter, Damian Trujillo, Jason Luke, Chunxiao Xu, BoMarelli, Jin Qi, Guozhong Qin, Huakui Yu, Molly Jenkins, Kin-Ming Lo, Joern-Peter Halle, Yan Lan, Matthew Taylor, Nicholas Vogelzang, Allen Cohn, Daniel Stepan, Robert Shumaker, Corina Dutcus, Matthew Guo, Emmett Schmidt, Drew Rasco, Marcia Brose, Nicholas Vogelzang, Christopher Di Simone, Sharad Jain, Donald Richards, Carlos Encarnacion, Drew Rasco, Robert Shumaker, Corina Dutcus, Daniel Stepan, Matthew Guo, Emmett Schmidt, Matthew Taylor, Nicholas Vogelzang, Carlos Encarnacion, Allen Cohn, Christopher Di Simone, Drew Rasco, Donald Richards, Matthew Taylor, Corina Dutcus, Daniel Stepan, Robert Shumaker, Matthew Guo, Emmett Schmidt, James Mier, Jeongshin An, Yeun-yeoul Yang, Won-Hee Lee, Jinho Yang, Jong-kyu Kim, Hyun Goo Kim, Se Hyun Paek, Jun Woo Lee, Joohyun Woo, Jong Bin Kim, Hyungju Kwon, Woosung Lim, Nam Sun Paik, Yoon-Keun Kim, Byung-In Moon, Filip Janku, David Tan, Juan Martin-Liberal, Shunji Takahashi, Ravit Geva, Ayca Gucalp, Xueying Chen, Kulandayan Subramanian, Jennifer Mataraza, Jennifer Wheler, Philippe Bedard

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: